Literature DB >> 14392945

Comparison of rescinnamine and reserpine as hypotensive agents.

F H SMIRK, E G McQUEEN.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh:

Substances:

Year:  1955        PMID: 14392945     DOI: 10.1016/s0140-6736(55)92116-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Rescinnamine in treatment of hypertension in hospital clinic and in general practice.

Authors:  R FIFE; J C MACLAURIN; J H WRIGHT
Journal:  Br Med J       Date:  1960-12-24

2.  Comparison of the effects of three rauwolfia alkaloids in hypertension.

Authors:  W I CRANSTON; B E JUEL-JENSEN; G J de LEE
Journal:  Br Med J       Date:  1961-04-01

3.  Treatment of arterial hypertension with recanescine: a new alkaloid isolated from Rauwolfia.

Authors:  J M PEPIN; B THERIEN; B VITYE; G LEMIEUX; J GENEST
Journal:  Can Med Assoc J       Date:  1957-03-15       Impact factor: 8.262

4.  Cardiac failure with reserpine.

Authors:  E MARLEY; C M PARE
Journal:  Br Med J       Date:  1956-02-04

5.  Trial of reserpine in treatment of schizophrenia.

Authors:  E A MARTIN; J N MOORE
Journal:  Br Med J       Date:  1957-01-05

6.  Treatment of arterial hypertension with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina.

Authors:  G LEMIEUX; A DAVIGNON; J GENEST
Journal:  Can Med Assoc J       Date:  1956-01-15       Impact factor: 8.262

7.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1955-12-03

8.  Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part I).

Authors:  Prakash N Tandon
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

9.  Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer.

Authors:  Jun Yu; Yan Ma; Jeanne Drisko; Qi Chen
Journal:  Curr Ther Res Clin Exp       Date:  2013-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.